This biotechnology company in South Asia has been operating for over two decades, focusing on developing and manufacturing vaccines and biotherapeutics. Their portfolio spans a wide range of products, including vaccines for various diseases like polio, typhoid, and rotavirus, as well as biotherapeutics for specific conditions. Key therapy areas include infectious diseases, immunology, and oncology. Their products are available in both prescription and over-the-counter forms, with dosage forms ranging from solids and liquids to injectables and orals. The company boasts manufacturing facilities that adhere to stringent EU and US GMP standards, ensuring high-quality production. The company has a strong track record in clinical research and holds several patents for its innovative products.

Established in 1992, this CTD dossier owner and manufacturer focuses on the research, development, production, and sales of human vaccines. As a leading CTD dossier owner and manufacturer in China, the company has developed a rich product portfolio and industry-leading scale. With significant international progress, this GMP manufacturer has expanded its business development to cover six regions and more than 20 countries. The company employs over 2,400 staff and has R&D centers and industrial bases in Shenzhen and Beijing. As a GMP manufacturer, it has undertaken numerous key scientific research projects at national, provincial, and municipal levels.

Established in 2002, this manufacturer employs nearly 4,500 staff and achieved an operating income of RMB 13.2 billion in the first half of 2021. As a CTD dossier owner and manufacturer, it specializes in human vaccines, with products available in 31 provinces across China. The manufacturer operates under strict GMP standards, ensuring high-quality production. With multiple production lines, it maintains its role as a CTD dossier owner and manufacturer, adhering to GMP guidelines.